Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 10/20 | 0.96 |
| ▸ | TSHR | P16473 | 3/20 | 0.96 |
| ▸ | LMNA | P02545 | 2/20 | 0.96 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.96 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.96 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.96 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.96 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.96 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.96 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.96 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.77 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.77 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.77 |
| ▸ | KDR | P35968 | 1/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.70 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.70 |
| ▸ | CA12 | O43570 | 1/20 | 0.65 |
| ▸ | CA1 | P00915 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butylparaben SCHEMBL5789201 | 0.98 | ESR1 (1.00) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL3647 | 0.98 | ESR1 (1.00) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL344001 | 0.96 | ESR1 (0.96) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL27203944 | 0.96 | ESR1 (0.96) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL761983 | 0.96 | ESR1 (0.96) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL5152448 | 0.96 | ESR1 (0.96) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL2325184 | 0.96 | ESR1 (0.96) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL9172319 | 0.96 | ESR1 (0.96) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL29377478 | 0.96 | ESR1 (0.96) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL27875265 | 0.96 | ESR1 (0.96) | ESR1TSHRLMNACYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024240033-A1 | KETAMINE LIQUID PREPARATION AND USE THEREOF | 宜昌人福药业有限责任公司 | 2024-11-28 | — | — | WO | claimed |
| CN-118662429-A | Ibuprofen eutectic rectal gel and preparation method thereof | 南京海融医药科技股份有限公司 | 2024-09-20 | — | — | CN | claimed |
| US-20230363380-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2023-11-16 | — | — | US | claimed |
| EP-3021832-B9 | PRESERVED ETHERIFIED CYCLODEXTRIN DERIVATIVES CONTAINING LIQUID AQUEOUS PHARMACEUTICAL COMPOSITION | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2023-03-15 | — | — | EP | claimed |
| US-20220079145-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2022-03-17 | — | — | US | claimed |
| EP-4580593-A1 | CLEANING PREPARATION FOR PREPARING FOR A SHAVE AND FOR FACE CLEANING | Beiersdorf AG (DE) | 2025-07-09 | — | — | EP | disclosed |
| EP-4306168-B1 | ISOXAZOLINE COMPOSITIONS AND USE THEREOF IN THE PREVENTION OR TREATMENT OF PARASITE INFESTATIONS IN ANIMALS | INTERVET INT BV (NL) | 2025-06-25 | — | — | EP | disclosed |
| EP-4504214-A1 | NOVEL ISOXAZOLINE COMPLEXES AND COMPOSITIONS THEREOF | Smartek International Inc. (US) | 2025-02-12 | — | — | EP | disclosed |
| WO-2024232970-A1 | NOVEL ISOXAZOLINE COMPLEXES AND COMPOSITIONS THEREOF | SMARTEK INTERNATIONAL INC (US) | 2024-11-14 | — | — | WO | disclosed |
| US-20240366572-A1 | ISOXAZOLINE COMPLEXES AND COMPOSITIONS THEREOF | FARBER MICHAEL (US) | 2024-11-07 | — | — | US | disclosed |
| CN-118662429-A | Ibuprofen eutectic rectal gel and preparation method thereof | 南京海融医药科技股份有限公司 | 2024-09-20 | — | — | CN | disclosed |
| EP-4360612-A1 | COSMETIC CLEANSING GEL HAVING HIGH TRANSPARENCY | Beiersdorf AG (DE) | 2024-05-01 | — | — | EP | disclosed |
| EP-3687497-B1 | TOPICAL COMPOSITION AND METHOD FOR TREATING AND PREVENTING ATOPIC DERMATITIS AND INFECTIONS RELATED TO BACTERIA BIOFILM | JOHNSON & JOHNSON CONSUMER INC (US) | 2023-06-28 | — | — | EP | disclosed |
| EP-3265135-B1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2023-06-07 | — | — | EP | disclosed |
| US-11464716-B1 | Semi-permanent colorant composition for hair | AMERICAN SPRAYTECH, L.L.C. (US) | 2022-10-11 | — | — | US | disclosed |
| EP-3313400-B1 | ISOXAZOLINE SOLUTION CONTAINING VITAMIN E FOR USE WITH SANITIZED DRINKING WATER | INTERVET INT BV (NL) | 2022-06-15 | — | — | EP | disclosed |
| US-11331305-B2 | Peptides for skin rejuvenation and methods of using the same | ANTEIS SA (CH) | 2022-05-17 | — | — | US | disclosed |
| US-20220079145-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2022-03-17 | — | — | US | disclosed |
| CN-114073669-A | Gel containing aryl propionic acid compound | 南京海融医药科技股份有限公司 | 2022-02-22 | — | — | CN | disclosed |
| US-11241385-B2 | Topical composition and method for treating and preventing atopic dermatitis and infections related to bacteria biofilm | JOHNSON & JOHNSON CONSUMER INC. (US) | 2022-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11331305-B2 | Peptides for skin rejuvenation and methods of using the same | CUTA, PLOD3, MMP13 | ESR1 4703/4885TSHR 3828/4885LMNA 408/4885 |
| US-20240366572-A1 | ISOXAZOLINE COMPLEXES AND COMPOSITIONS THEREOF | CCDC47, CAT, CTTN | ESR1 3294/4885TSHR 2889/4885LMNA 3653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.